Skip to collection list Skip to video grid
Skip to collection list Skip to video grid

All Video Abstracts

Safety and Immunogenicity of Cell-based Quadrivalent Influenza Vaccine: A Randomized Trial

Safety and immunogenicity of cell-based quadrivalent inactivated influenza vaccine is comparable to US-licensed vaccine indicated for use in children 6 month of age and older.

Read More
Read Less

categories

View more in
All Video Abstracts

Currently loaded videos are 1 through 15 of 527 total videos.

First page loaded, no previous page available
Load Next Page